Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Douglas J. Hughes

Director at Immunovant, Inc. (IMVT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $349K

Reported trades

Filed Stock Type Shares Price Value Since
Dec 3SEC IMVTImmunovant, Inc. Sell Plan 13,091122,682 held (−10%) $23.14 $303K +15.5%
Dec 3SEC IMVTImmunovant, Inc. Sell Plan 1,909120,773 held (−2%) $23.96 $46K +11.6%
  • Sell

    Director Douglas J. Hughes sold $303K of IMVT at $23.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Douglas J. Hughes sold $46K of IMVT at $23.96 — pre-scheduled 10b5-1 plan sale.